Our Product

We are developing a needle-free, second-generation nasal epinephrine product based on our proprietary epinephrine formulation and a unique two-spray nasal delivery system. Our guiding principle is that every single device should contain the full, power and protection of the epinephrine auto-injector, while providing patients with game-changing portability, accessibility, and convenience. Our approach is different and our results speak for themselves.

Our Device

We are developing an affordable, needle-free, small, and easy to use epinephrine nasal spray for the treatment of anaphylaxis. Studies have shown that, despite practice and prescription guidelines, most people at risk for anaphylaxis don't always carry one of their auto-injectors, and even fewer carry two epinephrine auto-injectors. This is due in part to size and cost of the products, putting patients at greater risk of severe complications during an allergic reaction. Our product is designed to provide patients with a life-saving treatment that is affordable, needle free, small, easy to use and complies with practice parameters.

Our product is not currently approved by the FDA or any international regulatory authority.

NDS1C - Bryn Pharma